Brief: Eterna Therapeutics Inc - Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq On Nov 22

Ernexa Therapeutics

23/11/2022 11:22

Nov 23 (Reuters) - Eterna Therapeutics Inc  ERNA.O :
    * ETERNA THERAPEUTICS INC - RECEIVED NOTICE OF DELISTING OR
FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD FROM
NASDAQ ON NOV 22
    * ETERNA THERAPEUTICS INC - COMPANY MAY ALSO PURSUE A
TRANSFER OF
ITS LISTING FROM NASDAQ GLOBAL MARKET TO NASDAQ CAPITAL MARKET
    * ETERNA THERAPEUTICS INC -  COMPANY CURRENTLY INTENDS TO
SUBMIT A
PLAN WITH RESPECT TO REGAINING COMPLIANCE WITH THE NASDAQ
LISTING RULE

Source text for Eikon: [ID:http://bit.ly/3tV0Y54]
Further company coverage:  ERNA.O 
 ((Reuters.Briefs@thomsonreuters.com;))